Oral vaccine research
Develops oral vaccines for human and animal health.
A biotechnology company focused on vaccine development and disease prevention. US Biologic develops oral vaccines and delivery systems targeting human and animal diseases. Its LymeShield System combines tick and rodent control methods with vaccine-coated pellets consumed by mice, aiming to reduce infection at its source. The company is also developing an oral flu vaccine designed for delivery without needles or refrigeration, in collaboration with the BARDA DRIVe division of the U.S. Department of Health and Human Services. Animal health projects include oral delivery approaches for poultry coccidiosis, Peste des Petites Ruminants, tick-borne diseases, African Swine Fever, Classical Swine Fever, and Foot & Mouth Disease. The work includes partnerships with government research agencies and the University of Edinburgh.
Disclosure: Profile information has been compiled from publicly available sources and has not yet been verified by the business.
Representative photos. Illustrative images for this category, not photos of US Biologic and not provided by the business.
Develops oral vaccines for human and animal health.
Pairs tick and rodent control with vaccine-coated pellets for mice.
Explores oral delivery approaches for livestock and poultry diseases.
No reviews yet — be the first to review US Biologic.
Sign in to write a review
No password needed. We only use your email to confirm the review is genuine.
Tell our moderators what is wrong with the review by this reviewer and we will take a look.